Evidence map›Paper›PMID 42435487›Full record

ArticleJournal of magnetic resonance (San Diego, Calif. : 1997)2026

High-resolution microtesla in-situ

Abubakar Abdurraheem, Joseph N Gyesi, Shiraz Nantogma, Patrick TomHon, Anna Samoilenko, Clementinah Oladun, Boyd M Goodson, Matthew S Rosen, Thomas Theis, Charlie Fehl and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of magnetic resonance (San Diego, Calif. : 1997), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abubakar AbdurraheemDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Joseph N GyesiDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Shiraz NantogmaDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Patrick TomHonDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Anna SamoilenkoDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Clementinah OladunDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Boyd M GoodsonSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.
Matthew S RosenA. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts, 02129, United States.
Thomas TheisHigh-Field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, 72076 Tübingen, Germany; Departments of Chemistry and Physics, North Carolina State University, Raleigh, North Carolina 27695, United States; Joint UNC-NC State Department of Biomedical Engineering, North Carolina State University, Raleigh, North Carolina 27606, United States.
Charlie FehlDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States.
Eduard Y ChekmenevDepartment of Chemistry, Molecular Therapeutics (MT) Program, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, United States. Electronic address: chekmenevlab@gmail.com.

Funding

Plug-and-play Hyperpolarized MRI of Metabolism on Clinical ScannersR01EB034197 · MASSACHUSETTS GENERAL HOSPITAL · 2025 to 2025
$594k
NIBIB NIH HHS R01 EB034197NIBIB NIH HHS R21 EB033872
6 · The paper itself

Abstract

SABRE-SHEATH (Signal Amplification by Reversible Exchange in SHield Enables Alignment Transfer to Heteronuclei) is a parahydrogen-based hyperpolarization technique increasingly used for metabolic sensing. Typically limited to 5-mm NMR tube reactors (0.5-1 mL volumes) and requiring manual sample transfer for quantification, SABRE remains constrained by its throughput. Here, we describe a new low-field magnetic resonance system that enables in-situ polarimetry of hyperpolarized [1-

Identifiers

PMID42435487
PMCPMC13429054

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.